Skip to main content
Laurus Labs Limited (NSE:LAURUSLABS)
India flag India · Delayed Price · Currency is INR
1,036.40
+15.40 (1.51%)
Mar 10, 2026, 10:00 AM IST

Laurus Labs Revenue

Laurus Labs had revenue of 17.78B INR in the quarter ending December 31, 2025, with 25.67% growth. This brings the company's revenue in the last twelve months to 67.22B, up 27.46% year-over-year. In the fiscal year ending March 31, 2025, Laurus Labs had annual revenue of 55.54B with 10.18% growth.

Revenue (ttm)
67.22B
Revenue Growth
+27.46%
P/S Ratio
8.20
Revenue / Employee
10.90M
Employees
6,167
Market Cap
551.19B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Mar 31, 202555.54B5.13B10.18%
Mar 31, 202450.41B-10.00B-16.55%
Mar 31, 202360.41B11.05B22.39%
Mar 31, 202249.36B1.22B2.54%
Mar 31, 202148.14B19.82B69.99%
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Mar 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Glenmark Pharmaceuticals 165.10B
Alkem Laboratories 142.53B
Aurobindo Pharma 331.82B
Ipca Laboratories 95.06B
Ajanta Pharma 52.02B
Mankind Pharma 139.14B
Zydus Lifesciences 260.89B
Emcure Pharmaceuticals 88.50B
Revenue Rankings

Laurus Labs News

More News